A key question in immunology is the difference between two processes that govern the maturation of T cells in the thymus. These processes are called positive and negative intrathymic selection. Both involve the recognition of selfpeptides bound to self major histocompatibility complex (MHC) molecules, but the outcome of the two processes is as radically different as their names suggest. Positive selection rescues a small population (less than 5%) of developing thymocytes from programmed cell death [1] . Negative selection then acts on this population to remove a further percentage of T cells bearing receptors that would be stimulated by self-peptide-self-MHC complexes in the periphery and could thereby induce autoimmunity [2] . Estimates for the loss of thymocytes at this step range from 5 to 70%, depending on the method of determination [3] [4] [5] [6] [7] [8] . How this gauntlet is negotiated by a given T cell, and how the extensive repertoire of mature T-cell receptors is sustained in the periphery, are questions that have puzzled and fascinated immunologists, biochemists, crystallographers, and many other scientists since the mid1970s. Recently, two studies [9, 10] have examined the role of self-peptides in positive selection and have essentially reached the same conclusion: positive selection of each T cell requires a limited set of specific self-peptides.
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Earlier attempts to examine this issue relied upon the culture of fetal thymuses (fetal thymic organ culture) from mice that lacked cell-surface expression of MHC class I molecules due to the deletion of the gene encoding the β 2 microglobulin component of the MHC class I molecule or deletion of the gene for the transporter associated with antigen processing (TAP). The absence of MHC class I molecules in these mice resulted in the inhibition of the generation of mature CD8 T cells, which requires interaction between the T-cell receptors and peptide-MHC class I complexes. To these cultures, differing amounts or differing sequences of peptides were added in the presence of β 2 microglobulin to restore surface expression of MHC class I molecules and allow CD8 T cells to be generated. Although in certain cases a single peptide could generate up to 20% of the normal numbers of CD8 T cells, in general, the more complex the mixture of peptides, the greater the number of CD8 T cells generated. The most effective peptides that drove this positive selection in culture turned out to be a mixture of peptides eluted from the thymus [11, 12] .
In subsequent experiments [13] [14] [15] [16] , specific peptides were added to fetal thymic organ cultures derived from mice lacking β 2 microglobulin or TAP and were used to select specific T cells bearing individual T-cell receptors. From these studies, it was concluded that peptides with the ability to stimulate T cells led to inactivation or elimination of the T cells, whereas peptides that could not stimulate T cells could, depending on their sequence, induce positive selection of activatable CD8 T cells [13] [14] [15] [16] . Recently, two groups succeeded in isolating naturally occurring self-peptides that could drive positive selection of CD8 T cells [17, 18] . Sequencing of these peptides revealed that they did not resemble the antigenic, stimulatory peptide or its positively selecting variants. Furthermore, one of the reports detected eight self-peptides that could mediate positive selection of clonal T cells expressing a single specific T-cell receptor, implying that there is significant degeneracy in the peptide component of positive selection. From this it was concluded that positive intrathymic selection was only partially specific for peptide, and that many different peptides in the thymus could select T cells expressing a given T-cell receptor. Thus, positive selection of CD8 T cells involves recognition of anything from one to more than eight peptides derived from self.
But what conditions induced positive selection of CD4 T cells, which recognize peptides bound to MHC class II molecules? This problem was approached in a similar way, using mice lacking various molecules required for peptide presentation by MHC class II molecules, namely the MHC class II invariant chain (Ii), which directs newly synthesized MHC class II molecules to the correct intracellular compartments for peptide binding, and H-2M, the MHC class II peptide-exchange factor. In the case of mice lacking Ii, CD4 T cells were weakly positively selected, because MHC class II molecules were present at very low levels in all tissues including the thymus [19] . In the case of mice lacking H-2M, the levels of surface MHC class II were somewhat decreased, and most of the MHC class II that was expressed on the surface of cells was bound to a single peptide called CLIP, for class II associated invariant chain peptide (a short peptide fragment derived from Ii that must be displaced from MHC class II molecules before they can present processed peptides). CLIP was identified as a naturally occurring self-peptide by elution from the MHC class II molecule I-A b [20] . The Ii-deficient mice were crossed with mice lacking the β chain of I-A b , resulting in offspring that were completely deficient in MHC class II expression. These mice were then themselves crossed with mice expressing a single specific covalent peptide-MHC complex comprising the β chain of the I-A b molecule bound to a peptide, Eα52-6, derived from the non-polymorphic α chain of the I-E MHC class II molecule: the resulting offspring present this one specific peptide on their cells [6, 19] .
About one-third to one-half of the normal number of CD4 T cells were positively selected in both the CLIP and the Eα52-68 'single-peptide' mice. The distribution of T-cell receptor β chains expressed on the T cells of these mice was almost normal, suggesting that these mice had a diverse repertoire of T-cell receptors. Both kinds of mice, however, showed a marked 'skewing' in their response to cells from mice of the same MHC genotype, I-A b , with up to 70% of T cells recognizing I-A b -bearing cells that presented a normal cargo of self-peptides. From these results, two conclusions were drawn. The first was that a single peptide could select a very diverse repertoire of T-cell receptors, as shown by the normal distribution of T-cell receptor β chains. The second was that negative selection played a major role in shaping the mature T-cell receptor repertoire, because up to 70% of the cells selected on one peptide bound to I-A b would have to be deleted under normal conditions in order to maintain self-tolerance.
In following up these conclusions, several groups crossed the H-2M-deficient mice with mice expressing various T-cell receptors that had been positively selected with I-A b -peptide complexes, and found that none of these Tcell receptors could be positively selected if H-2M was absent [8] . Moreover, when H-2M-deficient mice were crossed with transgenic mice engineered to express a particular T-cell receptor β chain [21] , an equivalent number of CD4 T cells was found in the thymus and peripheral lymphoid organs of the resulting offspring as that found in H-2M-deficient mice expressing the full range of endogenous T-cell receptor β chains. This finding proved that diversity in T-cell receptor β chains was not an adequate measure of T-cell receptor diversity. Indeed, the H-2M-deficient, T-cell receptor β chain transgenic mice manifested an equivalent high-frequency response to I-A b presenting a normal load of self-peptide as did mice with a full complement of T-cell receptor β chains, demonstrating that this I-A b -reactive repertoire was independent of the sequence of the T-cell receptor β chain. Finally, sequence analysis of the accompanying T-cell receptor α chains showed that there was a marked constraint in the length and sequence of the T-cell receptor α chain (a hallmark of a positively selected cell) in the absence, but not the presence, of H-2M. These results strongly indicated that most T cells selected in H-2M-deficient mice were positively selected by the CLIP peptide. A related study by Grubin et al. [22] showed that antibodies to I-A b that did not react with the I-A b -CLIP complex (and therefore reacted with I-A b bound to other peptides) were nevertheless able to reduce the numbers of CD4 T cells that were positively selected. Taken together, these data therefore suggest that both CLIP and non-CLIP peptides are involved in positive selection in H-2M-deficient mice.
Whether positive selection in mice engineered to express a single, dominant peptide is driven only by that particular peptide, or whether other peptides can also contribute to the selection process was the question that Barton and Rudensky [9] aimed to answer. These investigators had previously shown that by replacing the CLIP sequence in the Ii chain with the Eα52-68 sequence (creating Ii-Eα52-68) and expressing this chain in Ii-deficient mice, they could reliably observe very high levels of binding of the monoclonal antibody Y-Ae -specific for I-A b molecules bound to the Eα52-68 peptide [23] . These mice were then crossed with mice that lacked H-2M expression, and T-cell development was examined in the Ii-Eα52-68, Ii-deficient transgenic mice and in the Ii-Eα52-68, Ii-deficient, H-2M-deficient (double-deficient) mice.
The authors observed a significant inhibition of CD4 T-cell development in the thymus and peripheral lymphoid tissues of the Ii-Eα52-68, double-deficient mice. More importantly, they could inhibit T-cell development in fetal thymic organ culture with a monoclonal antibody directed at I-A b that recognizes most cell-surface I-A b molecules in all mice of the H-2 b MHC genotype; however, they could not inhibit T-cell development with the Y-Ae antibody -which bound to most surface I-A b molecules in these particular mice -whether the mice were deficient in Ii alone or in both Ii and H-2M. One caveat in these results is that the Y-Ae antibody is known to be able to inhibit negative selection in mice expressing the Y-Ae epitope and a T-cell receptor that recognizes this epitope (C. Viret and C.A.J., unpublished observations). Thus, the absence of inhibition by Y-Ae in the fetal thymic organ culture system may reflect a balance of inhibition of negative as well as positive selection, which would appear functionally as having no overall effect. This might be analyzed in terms of the strength of binding of the T-cell receptors to the I-Ab-Eα52-68 complex by T cells raised in the presence or absence of Y-Ae (Figure 1) .
A different approach was also reported recently by Baldwin et al. [10] . This group used monoclonal antibodies that bound to the complex comprising the MHC class II molecule I-E k bound to the peptide corresponding to residues 88-103 of moth cytochrome c. Several monoclonal antibodies specific for this complex were injected individually into pregnant females from day 15 of gestation: the authors found decreased numbers of CD4 T cells in mice injected with one particular monoclonal antibody that bound to the carboxy-terminal residues of the moth cytochrome c peptide and to residues in I-E k adjacent to the peptide in the complex. They demonstrated that the inhibition of positive selection by this monoclonal antibody was partial. Furthermore, they showed that the monoclonal antibody could be used to isolate several peptides from the thymus. The identity of these peptides is unknown, and the remaining positive selection seen in the presence of the monoclonal antibody suggests that further peptides that are involved in positive selection, but cannot be bound by the monoclonal antibody, may be present, at least on thymic epithelial cells.
Taken together, the studies of Barton and Rudensky [9] , Baldwin et al. [10] and Sant'Angelo et al. [21] indicate that self-peptides specifically direct the process of positive selection. This finding is further reinforced by earlier results from mice deficient in cathepsin L; these mice have a diminished expression of self-peptides that leads to a decrease in positive selection of CD4 T cells [24] . These studies also suggest that there are multiple self-peptides that can positively select CD4 T cells, exactly as was found in the systems that examined positive selection in CD8 T cells. Thus, the first part of the mystery surrounding CD4 T-cell development can be answered -positive intrathymic selection of individual CD4 T cells is specific for several distinct self-peptide-self-MHC class II complexes, as is negative intrathymic selection. How the peptides differ for these two selection processes, whether the difference is quantitative or qualitative, and whether there is a limited diversity in thymic self-peptides that drive positive selection are difficult problems that remain to be answered. Nevertheless, we can take comfort in the knowledge that both classes of MHC molecule use several bound self-peptides to induce positive intrathymic selection of both CD4 and CD8 T cells. 
